- Thermo Fisher (NYSE:TMO), Danaher (NYSE:DHR), Illumina (NASDAQ:ILMN), Agilent (NYSE:A) and Qiagen (NASDAQ:QGEN) all initiated with Outperform rating by Evercore ISI.
- Cerner (NASDAQ:CERN), athenahealth (NASDAQ:ATHN) and Health Management Systems (NASDAQ:HMSY) all initiated with Neutral ratings by Citigroup (NYSE:C).
- Humana (NYSE:HUM) added to U.S. 1 List at BofA/Merrill Lynch.
- Hologic (NASDAQ:HOLX) upgraded to Buy by BofA/Merrill Lynch.
- Edwards Lifesciences (NYSE:EW) upgraded to Overweight by Barclays (LON:BARC).
- CVS Health (NYSE:CVS) upgraded to Strong Buy by Raymond James.
- NuVasive (NASDAQ:NUVA) upgraded to Buy with a $71 (16% upside) price target by Needham.
- Zoetis (NYSE:ZTS) upgraded to Buy by Citigroup.
- DaVita (NYSE:DVA) upgraded to Buy by BofA/Merrill Lynch.
- Teva Pharmaceutical Industries (NYSE:TEVA) upgraded to Buy by Citigroup.
- Alexion Pharmaceuticals (NASDAQ:ALXN) downgraded to Outperform from Strong Buy by Raymond James.
- Now read: Sand In My Shoes - What To Do With Frozen Dividends
Original article